HSP90抑制剂17-DMAG在调节纤维化治疗中METTL3的治疗潜力
Soo Min Lee1, Myoung Seok Lee2, Hae Rim Jung3
1College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Journal of the American Society of Nephrology : JASN
|January 26, 2026
概括
17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) 通过降低METTL3的调节,有效地减少纤维化,这是纤维化的关键驱动因素. 这种药物重用策略为慢性脏病 (CKD) 提供了一个有前途的新治疗途径.
科学领域:
- 病中的表观遗传学和RNA修饰.
- 药理学向纤维化途径.
- 药物重新定位用于治疗干预.
背景情况:
- 纤维化是慢性病 (CKD) 的标志,涉及过度的细胞外基质沉积和功能衰退.
- 由METTL3调节的N6-甲基氨酸 (m6A) RNA甲基化,越来越多地被认为在促进纤维化中的作用.
- 向METTL3为缓解纤维化提供了潜在的治疗策略.
研究的目的:
- 研究17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) 在缓解纤维化的治疗潜力.
- 探索17-DMAG调节METTL3表达的机制及其对纤维化的下游影响.
主要方法:
- 基于转录组的药物重新定位确定了17-DMAG作为潜在的METTL3抑制剂.
- 纤维化的体外和体外模型被用于评估17-DMAG的抗纤维作用.
- 机械学研究调查了17-DMAG对METTL3表达,热冲击反应和相关信号通路 (HSP90,HSP70,JNK,c-Jun) 的影响.
主要成果:
- 根据剂量和时间,17-DMAG在细胞中减少了METTL3表达,并在体内减弱了纤维化.
- 用17-DMAG治疗降低了总m6A修饰,原沉积和益纤维菌标志物.
- 作为HSP90抑制剂的17-DMAG诱导了HSP70,抑制了JNK活性,抑制了c-Jun,从而降低了METTL3.
结论:
- 17-DMAG通过一种涉及HSP90抑制和c-Jun抑制的途径有效抑制METTL3表达.
- 这种机制导致纤维化在体外和体外实验模型中的衰减.
- 17-DMAG在治疗慢性瘤中的纤维化方面显示出显著的治疗潜力.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
594
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
594
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Kidney Structure
75.1K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.1K
Hormonal Regulation
36.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.0K
Negative Regulator Molecules
38.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Cystic Fibrosis: Pathogenesis
864
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
864


